<?xml version="1.0" encoding="UTF-8"?>
<fig id="antioxidants-10-00099-f003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>(
   <bold>a</bold>) Ht-EAF enhance the glucose uptake in insulin-resistant HepG2 cells. (
   <bold>b</bold>) Morphological changes of HT-EAF treated IR-HepG2 cells was screened by DAPI, PI, AO/EtBr, and rhodamine 123 and dual staining.(i) CK, (ii) 12.50 µg/mL of Ht-EAF (iii) 200 µg/mL of Ht-EAF (iv) 50 µg/mL of Ht-EAF. Data were expressed as mean ± standard deviation of three independent experiments. 
   <sc>*</sc>
   <italic>p</italic> &lt; 0.001 represent the statistically significant from the untreated HepG2 cells; * 
   <italic>p</italic> &lt; 0.05, ** 
   <italic>p</italic> &lt; 0.01, and *** 
   <italic>p</italic> &lt; 0.001 represents the significant differences from the 5 x 10
   <sup>7</sup> M insulin-treated control group.
  </p>
 </caption>
 <graphic xlink:href="antioxidants-10-00099-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
